Shares of Cantel Medical CMD moved higher by 4.9% in pre-market trading after the company reported Q4 results.
Earnings per share fell 61.90% over the past year to $0.24, which beat the estimate of ($0.01).
Revenue of $233,371,000 declined by 2.55% from the same period last year, which beat the estimate of $223,640,000.
Cantel Medical hasn't issued any earnings guidance for the time being.
Cantel Medical hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Sep 17, 2020
Time: 08:30 AM
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/2203/36688
Recent Stock Performance
52-week high: $90.79
52-week low: $20.81
Price action over last quarter: down 2.17%
Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (57% of fiscal 2019 sales), life sciences (22%), dental (18%), and dialysis (4%). Geographic exposure is primarily in the U.S., which accounts for 75% of revenue, with international markets making up the remaining 25%.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.